BeiGene Ltd (ONC): Balans kapitallashuviga qarzlar

BeiGene Corp (ONC) kompaniyasining korporativ logotipi

BeiGene Ltd (ONC) Osiyodagi past ishlab chiqish xarajatlarini AQSh va Yevropa Ittifoqidagi yuqori savdo marjalari bilan birlashtirib, Brukinsa muvaffaqiyatidan foydalanmoqda. Biznesning kengayish imkoniyatlari sinov bosqichidan keyin noyob dori vositalarining global taqsimoti orqali ta'minlanadi. Kompaniyaning kapitalizatsiyaga nisbatan qarz koeffitsiyenti uning qarz yuklamasi dinamikasini aks ettiradi, bunda 0.40 ushbu parametrning joriy holatini ifodalaydi. Uning jasur kashfiyotchi sifatidagi maqomi global hamjamiyatning brendga bo'lgan ishonchini mustahkamlaydi.

beigene.com (ONC): Qarzning sof aktivlarga nisbati 04.07.2022dan 28.10.2026gacha

BeiGene Ltd. (ONC) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi BeiGene Ltd|ONC - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi BeiGene Oncology|ONC - Korxonaning umumiy qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar BeiGene|ONC - Kompaniyaning buxgalteriya qiymati|Kapitallashuvning sof aktivlarga nisbati beigene.com|ONC - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati BeiGene Ltd|ONC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati BeiGene Corp|ONC - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati BeiGene Oncology
Kompaniyaning jamlanma tahliliyoti:ONC, BeiGene Ltd
BeiGene Oncology tomonidan chiqariladigan mahsulotlar

Investorlar, onkologik dori vositalarini global bozorga chiqarishning yuqori xarajatlari va geosiyosiy bosimni hisobga olgan holda, BeiGene Ltd (ONC) kengayish ko'lamini uning moliyaviy barqarorligi bilan qiyosiy bahlamoqdalar. Umumiy qarzning sof kapitalga nisbatini aks ettiruvchi ushbu koeffitsient, kapitalizatsiyaga nisbatan leveraj tarixini o'rganish orqali qarz yuklamasi va daromadlilik o'rtasidagi muvozanatni baholash imkonini beradi hamda kompaniyaning bankrotlik xavfisiz ishlanmalarni moliyalashtirish qobiliyatini tasdiqlaydi.

BeiGene Ltd raqobatchilari

Halozyme Therapeutics - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati revmed.com RVMD|AAPG (Ascentage Pharma) - Balans kapitallashuviga qarzlar|CGON: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati UroGen URGN|Qarzning sof aktivlarga nisbati Bicara Corp|PSNL - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati erasca.com|Balans kapitallashuviga qarzlar DCTH (Delcath Systems)|Qarzning balans qiymatiga nisbati Y-mAbs Therapeutics Inc YMAB|Qarzning balans qiymatiga nisbati AURA (Aura Bio)|Candel Therapeutics Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Accuray Incorporated (ARAY)|SLS - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar ACTU|Citius Oncology Inc. (CTOR) - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar TuHURA Biosciences Inc.|Qarzning balans kapitallashuviga nisbati Protara Tx|Fate Therapeutics, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar aadibio.com (WHWK)|Balans kapitallashuviga qarzlar TCRX|Sof aktivlarga qarzlar Champions Oncology Inc CSBR|Balans kapitallashuviga qarzlar XBIT|CVM - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar OSTX|RADX (radiopharmtheranostics.com) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Artiva Biotherapeutics Inc. (ARTV)|Qarzning balans qiymatiga nisbati Adlai Nortye Limited|Veru Pharma - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Tempest Therapeutics Corp TPST|Qarzning balans qiymatiga nisbati Xilio Therapeutics|Renovaro Biosciences - Qarzning sof aktivlarga nisbati|MURA - Qarzning balans kapitallashuviga nisbati|Kairos Pharma Ltd (KAPA) - Qarzning balans kapitallashuviga nisbati|OKUR - Qarzning balans qiymatiga nisbati|CytoMed Therapeutics Limited (GDTC) - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Curis Inc. (CRIS)|Qarzning balans qiymatiga nisbati APLM|Tharimmune - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar ADVB (advanbiomed.com)|GNPX - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Calidi Biotherapeutics Inc. CLDI|SBFM: Balans kapitallashuviga qarzlar|XBIO - Qarzning balans qiymatiga nisbati|SLRX (Salarius Pharmaceuticals, Inc.) - Balans kapitallashuviga qarzlar|Purple Biotech Ltd (PPBT) - Qarzning balans qiymatiga nisbati|AONC (American Oncology Network Inc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar BGNE|Qarzning balans kapitallashuviga nisbati Checkpoint Therapeutics CKPT|Qarzning balans qiymatiga nisbati elevationoncology.com (ELEV)|iCAD - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Ikena Oncology Inc. IKNA|NTBL (Notable Labs Inc.) - Balans kapitallashuviga qarzlar|VIRX: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati MorphoSys AG MOR|Qarzning sof aktivlarga nisbati nayabiosciences.com|AAPGV - Qarzning balans qiymatiga nisbati